Earnings call for the financial results of the fourth quarter on 22 May 2026

Board & Shareholder Meetings View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.0%1-day move

₹1823.60

prior close

₹1852.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-0.5-0.3-0.6+3.0+4.4+3.4+3.1+3.5+1.1-2.2-1.1+6.6—

Up moveDown movePending

AI summary

Sun Pharma announced it will release its Q4 FY2026 results (quarter ending 31 March 2026) on 22 May 2026. An earnings call is scheduled for the same day at 06:30 PM IST, lasting one hour, where senior management will discuss performance and take questions from participants. Investors can pre-register to join via telephone or audio webcast. A transcript of the call will be made available on the company website after the event.

Likely market impact

This is a routine scheduling announcement. Investors and analysts should note the date and time to participate in or listen to the earnings call for insights into the company's quarterly performance.